iANTHUS CAPITAL HOLDINGS (ITHUF) EPS (Weighted Average and Diluted) (2021 - 2026)
iANTHUS CAPITAL HOLDINGS's (ITHUF) quarterly EPS (Weighted Average and Diluted) came in at -$0.0 in Q1 2026, down 368.77% year-on-year from $0.0 in Q1 2025, and up 79.46% quarter-over-quarter from -$0.01 in Q4 2025.
iANTHUS CAPITAL HOLDINGS (ITHUF) EPS (Weighted Average and Diluted) (2021 - 2026) Analysis & Trends
iANTHUS CAPITAL HOLDINGS has disclosed EPS (Weighted Average and Diluted) across 6 years of filings, most recently posting -$0.0 for Q1 2026.
- EPS (Weighted Average and Diluted) for Q1 2026 came in at -$0.0, down 368.77% year-over-year; the trailing twelve-month figure through Mar 2026 was -$0.01 (down 200.0% YoY), and the FY2025 annual result was -$0.01, down 134.32% from the prior year.
- EPS (Weighted Average and Diluted) came in at -$0.0 for Q1 2026 at iANTHUS CAPITAL HOLDINGS, up from -$0.01 in the prior quarter.
- In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.04 in Q4 2022 to a low of -$3.14 in Q2 2023.
- The 5-year median for EPS (Weighted Average and Diluted) is -$0.0 (2025), against an average of -$0.4.
- Across the five-year window, EPS (Weighted Average and Diluted) tumbled 4727.82% in 2023 and surged 444.34% in 2024, its largest moves.
- iANTHUS CAPITAL HOLDINGS's EPS (Weighted Average and Diluted) stood at $0.04 in 2022, then tumbled by 107.26% to -$0.0 in 2023, then soared by 444.34% to $0.01 in 2024, then slumped by 200.0% to -$0.01 in 2025, then soared by 79.46% to -$0.0 in 2026.
- The last three EPS (Weighted Average and Diluted) figures came in at -$0.0 (Q1 2026), -$0.01 (Q4 2025), and -$0.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 0.31 |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 1.42 |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 5.82 |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 0.02 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 1.91 |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 0.11 |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -0.40 |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 1.80 |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -0.40 |
| 10 | iANTHUS CAPITAL HOLDINGS | - | - | 15.92 Mn | 0.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.00 |
| Dec 31, 2025 | -0.01 |
| Sep 30, 2025 | 0.00 |
| Jun 30, 2025 | 0.00 |
| Mar 31, 2025 | 0.00 |
| Dec 31, 2024 | 0.01 |
| Sep 30, 2024 | 0.00 |
| Jun 30, 2024 | 0.00 |
| Mar 31, 2024 | 0.00 |
| Dec 31, 2023 | 0.00 |
| Sep 30, 2023 | 0.00 |
| Jun 30, 2023 | -3.14 |
| Mar 31, 2023 | -2.90 |
| Dec 31, 2022 | 0.04 |
| Sep 30, 2022 | -0.01 |
| Jun 30, 2022 | -0.65 |
| Mar 31, 2022 | -0.06 |
| Dec 31, 2021 | -0.16 |
| Sep 30, 2021 | -0.09 |
| Jun 30, 2021 | -0.09 |